Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06717334 · ClinicalTrials.gov registry record
A Study of Lung Cancer Screening in People With Unexplained Weight Loss
A clinical trial of Lung Cancer Screening, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 409
- Enrollment target
- 8
- Study locations
NCT06717334 is a study of Lung Cancer Screening that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 409 participants, below the 471-participant average among 7 other Lung Cancer Screening trials with a reported enrollment target (13% lower). The trial reports 8 study locations across 2 states.
The verdict
NCT06717334, a study of Lung Cancer Screening, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 409 participants
- Enrollment target
- 8
- Study locations
Study Summary
The researchers are doing this study to see if people with unexplained weight loss who have lung cancer screening are more likely to have or develop lung cancer than people without unexplained weight loss. The lung cancer screening will involve use of low-dose computed tomography (LDCT), a CT scan that gives off very low doses of radiation and can make detailed pictures of the lungs to help find tumors. The study researchers will also analyze participants' blood samples to determine if blood testing can be used to help to diagnose lung cancer.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Low Dose CT imaging
- OTHER blood draws
- OTHER screening questionnaire
Study Locations (8)
New York
- Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities) - Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities) - Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
- Montefiore Health Systems (Montefiore Medical Center) - The Bronx
- Memorial Sloan Kettering Nassau (All Protocol Activities) - Uniondale
New Jersey
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities) - Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities) - Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 409 participants |
| Start Date | 2024-12-02 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06717334
The ClinicalTrials.gov registry entry for NCT06717334 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 409 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 471-participant average among 7 other Lung Cancer Screening trials with a reported enrollment target (13% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Cancer Screening appearing as the primary indexed condition, and to 3 interventions - of which Low Dose CT imaging is the first listed.
NCT06717334 reports 8 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT06717334 about?
NCT06717334 is a clinical study titled "A Study of Lung Cancer Screening in People With Unexplained Weight Loss". The researchers are doing this study to see if people with unexplained weight loss who have lung cancer screening are more likely to have or develop lung cancer than people without unexplained weight loss. The lung cancer screening will involve use of low-dose computed tomography (LDCT), a CT scan t...
What is the current status of trial NCT06717334?
This trial is currently recruiting. The enrollment target is 409 participants. The study started on 2024-12-02. Estimated completion is 2026-12.
What conditions does trial NCT06717334 study?
This clinical trial studies the following conditions: Lung Cancer Screening.
What interventions are being tested in trial NCT06717334?
The interventions under investigation include: Low Dose CT imaging (DIAGNOSTIC_TEST), blood draws (OTHER), screening questionnaire (OTHER).
Who is sponsoring clinical trial NCT06717334?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06717334 being conducted?
This trial has 8 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Advancing Lung Cancer Screening One Text at a Time
RECRUITING · NA
-
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
RECRUITING
-
CPRIT: Patient Adherence to Lung Cancer Screening
RECRUITING
-
Digitally Enhanced Smoking Cessation for High Risk Smokers
ACTIVE NOT RECRUITING · NA
-
Multilevel Interventions to Increase Adherence to Lung Cancer Screening
ACTIVE NOT RECRUITING · NA
-
The SHARED, Project, Lung Cancer Screening for African American Men (AAM)
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.